These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 22474873
1. Focal nodular hyperplasia on MRI using a hepatocyte-specific contrast agent at 1.5 Tesla vs. 3.0 Tesla field strength. Chang KJ. Med Health R I; 2012 Feb; 95(2):43-5. PubMed ID: 22474873 [No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Fowler KJ, Brown JJ, Narra VR. Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400 [Abstract] [Full Text] [Related]
7. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium. Karam AR, Shankar S, Surapaneni P, Kim YH, Hussain S. J Magn Reson Imaging; 2010 Aug; 32(2):341-4. PubMed ID: 20677260 [Abstract] [Full Text] [Related]
8. Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver. Asbach P, Klessen C, Koch M, Hamm B, Taupitz M. Clin Imaging; 2007 Aug; 31(4):244-52. PubMed ID: 17599618 [Abstract] [Full Text] [Related]
9. [Multiple regeneration nodes in the temporal follow-up of Budd-Chiari syndrome after TIPS]. Pennekamp W, Willert J, Wittl E. Rofo; 2011 Mar; 183(3):288-90. PubMed ID: 21113869 [No Abstract] [Full Text] [Related]
10. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Husarik DB, Gupta RT, Ringe KI, Boll DT, Merkle EM. Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599 [Abstract] [Full Text] [Related]
11. The role of ADC measurement in differential diagnosis of focal hepatic lesions. Onur MR, Çiçekçi M, Kayalı A, Poyraz AK, Kocakoç E. Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418 [Abstract] [Full Text] [Related]
12. [Differentiation of focal liver lesions using contrast-enhanced MRT]. Heintz P, Ehrenheim C. Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880 [Abstract] [Full Text] [Related]
13. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging. Liu X, Zhou L, Peng W, Qian M. Acta Radiol; 2011 Jun 01; 52(5):575-80. PubMed ID: 21498291 [Abstract] [Full Text] [Related]
14. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging. Ahn SJ, Choi JY, Kim KA, Kim MJ, Baek SE, Kim JH, Song HT. J Comput Assist Tomogr; 2011 Jun 01; 35(1):81-5. PubMed ID: 21160434 [Abstract] [Full Text] [Related]
15. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E. Clin Radiol; 2001 May 01; 56(5):410-5. PubMed ID: 11384141 [Abstract] [Full Text] [Related]
16. Staging hepatic fibrosis: computer-aided analysis of hepatic contours on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced hepatocyte-phase magnetic resonance imaging. Goshima S, Kanematsu M, Kobayashi T, Furukawa T, Zhang X, Fujita H, Watanabe H, Kondo H, Moriyama N, Bae KT. Hepatology; 2012 Jan 01; 55(1):328-9. PubMed ID: 21932401 [No Abstract] [Full Text] [Related]
17. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]. Olivetti L, Grazioli L, Maroldi R, Matricardi L, Milanesio L. Radiol Med; 1992 Apr 01; 83(4):353-60. PubMed ID: 1318558 [Abstract] [Full Text] [Related]